Table 1. SRI at Wk 52, n (%)*
| Placebo | Belimumab | ||
|---|---|---|---|
| 1 mg/kg | 10 mg/kg | ||
| Both corticosteroidsand MMF at BL | n=58 | n=55 | n=63 |
| 14 (24.1%) | 19 (34.5%) | 33 (52.4%) | |
| p=0.22 | p=0.001 | ||
| MMF at BL | n=61 | n=61 | n=67 |
| 15 (24.6%) | 22 (36.1%) | 35 (52.2%) | |
| p=0.13 | p<0.001 | ||
| Corticosteroidsat BL | n=488 | n=487 | n=478 |
| 189 (38.7%) | 225 (46.2%) | 254 (53.1%) | |
| p=0.01 | p<0.001 | ||
*Dropout = failure.